The only prospective, multi-center, randomized trial to examine chemotherapy before surgery for organ preservation in patients w nose and sinus cancer shows a striking improvement for patients that warrants a larger confirmatory study. ECOG-ACRIN EA3163…
“The results support chemotherapy before surgery as an effective intervention to improve preservation of vital organs, bone, and tissue in patients w nose/sinus cancer” @DrNabilSaba @WinshipAtEmory who led ECOG-ACRIN EA3163 w Barbara Burtness @YaleCancer …
ECOG-ACRIN EA3163 Trial: Organ preservation for Sino-nasal SCC. https://t.co/v5SRUM04K9 https://t.co/3orxhUm619